The global Peptide Based Cancer Therapeutics Market  size is expected to reach USD 516.75 Million in 2028 and register a CAGR of 6.4% over the forecast period, according to a latest report by Reports and Data. Major factors driving market revenue growth are development of advanced peptide synthesizers, availability of funding for R&D, rising number of research activities, and...